Sergio Quezada, PhDProfessorial Research Fellow at UCL Cancer Institute
Dr. Quezada earned an undergraduate degree in biochemistry from the P. Universidad Católica de Chile and a Ph.D. from Dartmouth Medical School in the US. In 2004, he joined the laboratory of Dr. James Allison at MSKCC, where he studied the mechanisms governing anti-tumour T-cell immunity. In November 2011, Dr. Quezada joined UCL Cancer Institute in the United Kingdom as head of the Immune Regulation and Tumour Immunotherapy group. His research at UCL focuses in the study of the mechanism of action of anti-CTLA-4, anti-PD-1 and other immune-modulatory antibodies targeting co-inhibitory and co-stimulatory pathways. His team also focuses in the characterization and interrogation of immune reactivity and function within the microenvironment of different human cancers including melanoma, lung and kidney cancers. Dr. Quezada was a recipient of Dartmouth’s John W. Strohbern Medal for excellence in biomedical research, the CRUK Career Development Fellowship and a CRUK Senior Cancer Research Fellowship.